Fayez Sarofim & Co’s Colgate-Palmolive CL Stock Holding History

Fayez Sarofim & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.13M	Sell	25,022 -3,046	-11%	-$271K	0.01%	147
2025 Q4	$2.22M	Sell	28,068 -520	-2%	-$40.8K	0.01%	148
2025 Q3	$2.29M	Sell	28,588 -100	-0.3%	-$8.53K	0.01%	151
2025 Q2	$2.61M	Sell	28,688 -100	-0.3%	-$9.13K	0.01%	141
2025 Q1	$2.7M	Sell	28,788 -3,836	-12%	-$343K	0.01%	139
2024 Q4	$2.97M	Sell	32,624 -194	-0.6%	-$18.5K	0.01%	138
2024 Q3	$3.41M	Sell	32,818 -776	-2%	-$79.1K	0.01%	130
2024 Q2	$3.26M	Sell	33,594 -984	-3%	-$90.8K	0.01%	125
2024 Q1	$3.11M	Sell	34,578 -2,579	-7%	-$219K	0.01%	130
2023 Q4	$3.1M	Sell	37,157 -6,699	-15%	-$504K	0.01%	126
2023 Q3	$3.12M	Sell	43,856 -3,403	-7%	-$254K	0.01%	128
2023 Q2	$3.64M	Hold	47,259	–	–	0.01%	118
2023 Q1	$3.55M	Hold	47,259	–	–	0.01%	121
2022 Q4	$3.72M	Sell	47,259 -3,580	-7%	-$268K	0.01%	118
2022 Q3	$3.57M	Sell	50,839 -750	-1%	-$58.8K	0.01%	117
2022 Q2	$4.13M	Sell	51,589 -255	-0.5%	-$19.9K	0.02%	120
2022 Q1	$3.93M	Buy	51,844 +4,200	+9%	+$333K	0.01%	129
2021 Q4	$4.07M	Buy	47,644 +2,200	+5%	+$172K	0.01%	135
2021 Q3	$3.44M	Sell	45,444 -1,805	-4%	-$143K	0.01%	130
2021 Q2	$3.84M	Sell	47,249 -168	-0.4%	-$13.7K	0.01%	128
2021 Q1	$3.74M	Buy	47,417 +296	+0.6%	+$23.2K	0.01%	118
2020 Q4	$4.03M	Buy	47,121 +888	+2%	+$73.4K	0.02%	113
2020 Q3	$3.57M	Sell	46,233 -6,157	-12%	-$469K	0.02%	112
2020 Q2	$3.84M	Buy	52,390 +2,380	+5%	+$169K	0.02%	109
2020 Q1	$3.32M	Sell	50,010 -2,782	-5%	-$196K	0.02%	107
2019 Q4	$3.63M	Sell	52,792 -2,855	-5%	-$195K	0.02%	117
2019 Q3	$4.09M	Sell	55,647 -2,045	-4%	-$148K	0.02%	108
2019 Q2	$4.13M	Buy	57,692 +1,035	+2%	+$73.5K	0.02%	112
2019 Q1	$3.88M	Buy	56,657 +10,977	+24%	+$709K	0.02%	116
2018 Q4	$2.72M	Sell	45,680 -320	-0.7%	-$20K	0.02%	118
2018 Q3	$3.08M	Sell	46,000 -3,000	-6%	-$200K	0.02%	118
2018 Q2	$3.18M	Sell	49,000 -2,025	-4%	-$132K	0.02%	114
2018 Q1	$3.66M	Sell	51,025 -90	-0.2%	-$6.48K	0.02%	111
2017 Q4	$3.86M	Sell	51,115 -150	-0.3%	-$11K	0.02%	109
2017 Q3	$3.73M	Sell	51,265 -105	-0.2%	-$7.57K	0.02%	111
2017 Q2	$3.81M	Sell	51,370 -220	-0.4%	-$16.3K	0.02%	112
2017 Q1	$3.78M	Hold	51,590	–	–	0.02%	116
2016 Q4	$3.38M	Hold	51,590	–	–	0.02%	118
2016 Q3	$3.83M	Sell	51,590 -400	-0.8%	-$29.6K	0.02%	116
2016 Q2	$3.81M	Sell	51,990 -333	-0.6%	-$23.7K	0.02%	115
2016 Q1	$3.7M	Sell	52,323 -10,765	-17%	-$716K	0.02%	114
2015 Q4	$4.2M	Buy	63,088 +3,068	+5%	+$204K	0.02%	109
2015 Q3	$3.81M	Sell	60,020 -2,000	-3%	-$131K	0.02%	112
2015 Q2	$4.06M	Sell	62,020 -160	-0.3%	-$10.9K	0.02%	107
2015 Q1	$4.31M	Sell	62,180 -6,771	-10%	-$468K	0.02%	105
2014 Q4	$4.77M	Sell	68,951 -1,260	-2%	-$85.1K	0.02%	104
2014 Q3	$4.58M	Buy	70,211 +460	+0.7%	+$30.3K	0.02%	104
2014 Q2	$4.76M	Hold	69,751	–	–	0.02%	106
2014 Q1	$4.53M	Sell	69,751 -4,754	-6%	-$300K	0.02%	104
2013 Q4	$4.86M	Buy	+74,505	New	+$4.77M	0.02%	101
2013 Q2	$4.36M	Buy	+76,115	New	+$4.52M	0.02%	97

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Fayez Sarofim & Co's CL Position: Q1 2026 in Review

Fayez Sarofim & Co reduced its Colgate-Palmolive (CL) stake by 11% in Q1 2026, selling an estimated $271K and leaving 25,022 shares worth $2.13M. The position accounts for 0.01% of the portfolio, ranked #147.

Fayez Sarofim & Co first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $4.86M in Q4 2013. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Fayez Sarofim & Co held 25,022 shares of Colgate-Palmolive worth $2.13M as of Q1 2026.
Fayez Sarofim & Co sold 3,046 Colgate-Palmolive shares in Q1 2026, an estimated $271K.
Colgate-Palmolive made up 0.01% of Fayez Sarofim & Co's portfolio in Q1 2026, its #147 holding.
Fayez Sarofim & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
Fayez Sarofim & Co's Colgate-Palmolive position peaked at $4.86M in Q4 2013.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.